Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Fuhr

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|February 10, 2000
Problems and perspectives of phenotyping for drug-metabolizing enzymes in manM Zaigler, I Tantcheva-Poór, U Fuhr
British Journal of Anaesthesia|May 24, 2000
Pharmacokinetics of inhaled anaesthetics in a clinical setting: description of a novel method based on routine monitoring dataS Rietbrock, H Wissing, I Kuhn, et al.
British Journal of Anaesthesia|May 24, 2000
Pharmacokinetics of inhaled anaesthetics in a clinical setting: comparison of desflurane, isoflurane and sevofluraneH Wissing, I Kuhn, S Rietbrock, et al.
The American Journal of Medicine|November 30, 1989
Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigationsS Harder, U Fuhr, A H Staib, et al.
British Journal of Clinical Pharmacology|July 1, 1990
Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsuleS Harder, U Fuhr, D Beermann, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1989
Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acidA H Staib, S Harder, U Fuhr, et al.
Pneumologie (Stuttgart, Germany)|June 1, 1997
[Bioavailability of a new theophylline chewable pill]A H Staib, R Mäuser, M Zaigler, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1992
Differences in absorption of BAY u 3405 along the human gastrointestinal tractU Fuhr, J Hoyer, W Ritter, et al.
Pharmacogenetics|June 22, 1999
Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine testI Tantcheva-Poór, M Zaigler, S Rietbrock, et al.
The Pharmacogenomics Journal|June 6, 2007
The clinical role of genetic polymorphisms in drug-metabolizing enzymesD Tomalik-Scharte, A Lazar, U Fuhr, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
International Journal of Clinical Pharmacology and Therapeutics|February 10, 2000
Problems and perspectives of phenotyping for drug-metabolizing enzymes in manM Zaigler, I Tantcheva-Poór, U Fuhr
British Journal of Anaesthesia|May 24, 2000
Pharmacokinetics of inhaled anaesthetics in a clinical setting: description of a novel method based on routine monitoring dataS Rietbrock, H Wissing, I Kuhn, et al.
British Journal of Anaesthesia|May 24, 2000
Pharmacokinetics of inhaled anaesthetics in a clinical setting: comparison of desflurane, isoflurane and sevofluraneH Wissing, I Kuhn, S Rietbrock, et al.
The American Journal of Medicine|November 30, 1989
Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigationsS Harder, U Fuhr, A H Staib, et al.
British Journal of Clinical Pharmacology|July 1, 1990
Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsuleS Harder, U Fuhr, D Beermann, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1989
Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acidA H Staib, S Harder, U Fuhr, et al.
Pneumologie (Stuttgart, Germany)|June 1, 1997
[Bioavailability of a new theophylline chewable pill]A H Staib, R Mäuser, M Zaigler, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1992
Differences in absorption of BAY u 3405 along the human gastrointestinal tractU Fuhr, J Hoyer, W Ritter, et al.
Pharmacogenetics|June 22, 1999
Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine testI Tantcheva-Poór, M Zaigler, S Rietbrock, et al.
The Pharmacogenomics Journal|June 6, 2007
The clinical role of genetic polymorphisms in drug-metabolizing enzymesD Tomalik-Scharte, A Lazar, U Fuhr, et al.
Pageof 9